What drug price deregulation means for your portfolio?
The pharmaceutical sector in Pakistan has long operated under tight regulatory constraints, particularly regarding drug pricing. But in February 2024, a major shift occurred: the...
OMC sales climb for third straight month: can the momentum hold?
The oil marketing sector in Pakistan is showing signs of resilience, with volumetric sales for May 2025 marking the third consecutive monthly increase. Total OMC...
Inflation drops again in May, but will the relief last?
Pakistan’s inflation continued its downward march in May 2025, with prices falling 0.3 percent compared to April. This marks the second consecutive month of monthly...
M&A Alert: Fauji and KAPCO team up for cement takeover
In a bold move that could reshape the landscape of Pakistan’s cement industry, Fauji Foundation and Kot Addu Power Company Limited (KAPCO) have submitted a...
Pak Datacom’s new revenue engines are online: should you pay attention?
Pak Datacom (PAKD) reported a net profit of PKR 110 million for the nine-month period ending March 2025. While profit growth was modest at just...
How is tax policy turning Airlink into a market leader?
Pakistan’s smartphone market is undergoing a major shift. Consumer preferences are increasingly tilting toward affordable and reliable technology, and AirLink Communication Ltd. (AIRLINK) is riding...
Why pharma exports could be Pakistan’s next billion-dollar opportunity?
Pakistan’s pharmaceutical industry has been on an upward trajectory thanks to deregulation, margin expansion, and a rising domestic market. But a far less discussed, and...
Why GLAXO’s antibiotic portfolio is its greatest asset?
In Pakistan’s rapidly evolving pharmaceutical landscape, one drug category continues to reign supreme: antibiotics. Valued at approximately PKR 185 billion in FY25 and growing at...